Literature DB >> 12137065

I beg to differ.

Nancy Olivieri.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12137065      PMCID： PMC116622     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  The Olivieri dispute: no end in sight?

Authors:  Miriam Shuchman
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

2.  The deferiprone controversy: time to move on.

Authors:  C David Naylor
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

3.  Dances with the pharmaceutical industry.

Authors:  Elaine Gibson; Françoise Baylis; Steven Lewis
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

4.  Questions of interest.

Authors: 
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

5.  Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.

Authors:  N F Olivieri; G M Brittenham; C E McLaren; D M Templeton; R G Cameron; R A McClelland; A D Burt; K A Fleming
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245
  5 in total
  1 in total

1.  Setting the record straight.

Authors:  David Naylor
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.